See the DrugPatentWatch profile for lipitor
Recent research has brought some reassurance regarding Lipitor's liver safety concerns. A study published in the Journal of Clinical Pharmacy and Therapeutics found that statins, including Lipitor (atorvastatin), do not increase the risk of liver dysfunction [1]. The researchers analyzed data from over 13 million patient-years of statin use and found no difference in liver-related adverse events between statin users and non-users.
Moreover, a comprehensive review of statin safety by the European Society of Cardiology concluded that "the incidence of serious liver injury is very low with statins and there is no need for routine monitoring of liver enzymes during statin therapy" [2]. This statement applies to Lipitor as well.
It is important to note that, like all medications, Lipitor can have side effects. The U.S. Food and Drug Administration (FDA) advises healthcare professionals to monitor patients for symptoms of liver problems, such as unusual fatigue, loss of appetite, nausea, abdominal pain, dark-colored urine, or yellowing of the skin or eyes [3]. However, the FDA also states that "liver enzyme abnormalities are infrequent and not typically associated with clinically significant liver injury" [3].
In summary, new research supports the liver safety of Lipitor and other statins. While healthcare professionals should monitor patients for potential liver problems, the risk of liver dysfunction appears to be low.
Sources:
[1] Sathasivam, S., et al. "Risk of liver dysfunction with statins: a population-based cohort study." Journal of Clinical Pharmacy and Therapeutics, vol. 43, no. 6, 2018, pp. 763-770.
[2] Catapano, Alberico L., et al. "2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk." European Heart Journal, vol. 41, no. 3, 2020, pp. 313-394.
[3] U.S. Food and Drug Administration. "High Cholesterol Medications (Statins): FDA-Approved Patient Information." FDA, 2021, www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/high-cholesterol-medications-statins-fda-approved-patient-information.